This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:


trusted source


New study offers clues into how cancer spreads to the brain

New study offers clues to how cancer spreads to the brain
BR cancer cells extravasate toward astrocyte cells. A,E) Schematic of a BBN with (A) astrocytes or (E) microglia in the brain niche chamber. Cancer cells in the top flow chamber interact with the BBN for 2- and 9 days. B,F) Legend for (C) and (G) respectively. Each quadrant shows interactions between cancer cells and brain niche cells. The yellow dashed line represents the endothelial barrier. Red and blue overlay denote a distance from barrier > 150 μm. (C,G) 2D density plot of cancer cell and (C) astrocyte or (G) microglia interaction for MDA-MB-231, MDA-MB-231-BR, JIMT-1, JIMT-1-BR for 2 and 9 days. (D,H) Representative fluorescent confocal images of cancer cells in BBN chips with (D) astrocytes or (H) microglia after 9 days. Images are in the XY and YZ planes, scale bar = 125 μm. Credit: Advanced NanoBiomed Research (2023). DOI: 10.1002/anbr.202200036

When cancer spreads to the brain, treatment options fall off. Most of the drugs designed to target metastases do not cross the blood-brain barrier or are ineffective at treating brain metastases.

"Understanding how cancer cells thrive or fail in the brain niche could help us develop new treatments targeting these molecular processes," said Sofia Merajver, M.D., Ph.D., the Greater Good Breast Cancer Research Professor at the University of Michigan Rogel Cancer Center.

To understand the molecular processes that influence how cancer cells pass through the blood-brain barrier, Merajver and colleagues used two microfluidic chips that mapped cancer cell migration to the brain and looked at what was happening in the blood-brain niche. Results are published in the journal Advanced NanoBiomed Research.

Using breast cancer cell lines, they found that Dkk-1, a cytokine released by the astrocytes, triggers the cancer cells to migrate. Dkk-1 is known to play a role in in Wnt signaling, a key signaling pathway linked to cancer progression.

"Crosstalk between brain niche cells and cancer cells allows invading to permeate the . Reducing Dkk-1 levels near invading might disrupt this crosstalk and prevent brain metastases," said corresponding author Christopher R. Oliver, Ph.D., a post-doctoral fellow in the Merajver Lab.

Credit: University of Michigan

More information: Trisha M. Westerhof et al, Blood–Brain Barrier Remodeling in an Organ‐on‐a‐Chip Device Showing Dkk1 to be a Regulator of Early Metastasis, Advanced NanoBiomed Research (2023). DOI: 10.1002/anbr.202200036

Citation: New study offers clues into how cancer spreads to the brain (2023, March 31) retrieved 15 June 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Aggressive breast cancers store large amounts of energy, which enables it to spread: study


Feedback to editors